Top & Current
Fri, September 6, 2024
[ Fri, Sep 06th 2024
] - WOPRAI
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
Fri, March 8, 2024
[ Fri, Mar 08th 2024
] - WOPRAI
Fri, October 20, 2023
[ Fri, Oct 20th 2023
] - WOPRAI
Tue, November 15, 2022
[ Tue, Nov 15th 2022
] - WOPRAI
Mon, November 14, 2022
[ Mon, Nov 14th 2022
] - WOPRAI
Mon, October 17, 2022
[ Mon, Oct 17th 2022
] - WOPRAI
Fri, September 30, 2022
[ Fri, Sep 30th 2022
] - WOPRAI
Fri, July 29, 2022
Mon, June 13, 2022
[ Mon, Jun 13th 2022
] - WOPRAI
Tue, March 2, 2021
[ Tue, Mar 02nd 2021
] - WOPRAI
Fri, October 16, 2020
[ Fri, Oct 16th 2020
] - WOPRAI
Tue, May 19, 2020
Thu, December 12, 2019
[ Thu, Dec 12th 2019
] - WOPRAI
Tue, November 12, 2019
Fri, September 6, 2019
[ Fri, Sep 06th 2019
] - WOPRAI
Mon, May 13, 2019
Fri, May 3, 2019
Mon, October 8, 2018
[ Mon, Oct 08th 2018
] - WOPRAI
Fri, June 15, 2018
[ Fri, Jun 15th 2018
] - WOPRAI
Mon, November 13, 2017
Fri, January 20, 2017
Mon, August 3, 2015
[ Mon, Aug 03rd 2015
] - WOPRAI
Tue, March 17, 2015
[ Tue, Mar 17th 2015
] - WOPRAI
Thu, March 5, 2015
[ Thu, Mar 05th 2015
] - WOPRAI
Mon, November 3, 2014
[ Mon, Nov 03rd 2014
] - WOPRAI
Mon, July 28, 2014
[ Mon, Jul 28th 2014
] - WOPRAI
Tue, June 10, 2014
[ Tue, Jun 10th 2014
] - WOPRAI
Fri, April 4, 2014
[ Fri, Apr 04th 2014
] - WOPRAI
Fri, March 14, 2014
[ Fri, Mar 14th 2014
] - WOPRAI
Mon, November 4, 2013
[ Mon, Nov 04th 2013
] - WOPRAI
Mon, September 16, 2013
[ Mon, Sep 16th 2013
] - WOPRAI
Fri, September 13, 2013
[ Fri, Sep 13th 2013
] - WOPRAI
Mon, June 4, 2012
[ Mon, Jun 04th 2012
] - WOPRAI
Chris Schott Upgraded (AMRX) to Hold and Held Target at $9 on, Sep 6th, 2024
Chris Schott of JP Morgan, Upgraded "Amneal Pharmaceuticals, Inc." (AMRX) to Hold and Held Target at $9 on, Sep 6th, 2024.
Chris has made no other calls on AMRX in the last 4 months.
There are 3 other peers that have a rating on AMRX. Out of the 3 peers that are also analyzing AMRX, 0 agree with Chris's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Chris
- Balaji Prasad of "Barclays" Maintained at Buy with Increased Target to $10 on, Tuesday, August 13th, 2024
- Les Sulewski of "Truist Securities" Maintained at Strong Buy with Increased Target to $10 on, Monday, August 12th, 2024
- Nathan Rich of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $8 on, Monday, May 6th, 2024